Oil and Gas Stocks Sector Close-Up; Trading for (OTCBB: AAPH), (OTCQB: USOG), (NYSE:CVX), (NYSE:NOV)
Point Roberts, WA – October 10, 2010 (Investorideas.com Energy Newswire) - InvestorIdeas.com, leader in sector research for investors, reports on Oil and Gas Stocks news and trading for Friday’s close for energy investors.
Oil and Gas Stocks include American Petro-hunter Inc (OTCBB: AAPH), United States Oil & Gas Corp (OTCQB: USOG), Chevron Corp (NYSE:CVX), and National Oilwell Varco, Inc (NYSE:NOV)
Sector Snapshot: (as of close Oct 8th)
American Petro-hunter Inc (OTCBB: AAPH) trading at $0.32
United States Oil & Gas Corp (OTCQB: USOG) trading at $0.0021 - 0.0026 on over 19 million
Chevron Corp (NYSE:CVX), trading at $83.94, up 0.42 (0.50%)
National Oilwell Varco, Inc (NYSE:NOV) trading at 46.61, up 0.97 (2.13%)
Market Snapshot:
Crude Oil Nov 10 83.13 +0.47 Crude Oil Nov 10
Gold Oct 10 1,346.70 +3.80 Gold Oct 10
Natural Gas Nov 10 3.64 -0.01 Natural Gas Nov 10
RBOB Gasoline Nov 10 2.16 +0.01
Oil and Gas Stocks to Watch News
American Petro-hunter Inc (OTCBB: AAPH) Key Highlights and Recent Press
Latest News: October 4th
American Petro-Hunter Prepares NOJ26 for Commercial Oil Production at North Oklahoma Project
“American Petro-Hunter, Inc. is pleased to advise that the previously announced plans for completion of the NOJ26 well at the North Oklahoma Oil Project have commenced. Operations are now underway in order to prepare the well for commercial production. This includes the purchase of a pumping unit and tank battery which are currently undergoing installation at the well site.
Based on an assessment of the well and analysis of the oil shows, the partners have concluded to commence the completion program by first addressing the lower of the two 40 foot pay zones. The oil shale will be perforated, acidized and subsequently put on pump. The completion efforts will culminate in swab and flow testing of the oil bearing shale formation to determine what the zone can and will deliver on a BPD (barrel per day) basis. The Company is confident that based on strong oil shows and subject to fracture stimulation in the shale, the lower pay zone will produce at rates in excess of the No. 1 well which tested at 80 BPD under similar conditions. The upper pay zone directly above the shale at NOJ26 exhibited excellent oil shows and log responses and will be put into production following a period of evaluation in order to maximize the response from the shale..”
American Petro-hunter Inc. is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets.
Full news: http://finance.yahoo.com/news/American-PetroHunter-Prepares-iw-3195731505.html?x=0&.v=1
Website: www.aaphreport.com
Visit the AAPH showcase profile on Investorideas.com to learn more:
http://www.investorideas.com/CO/AAPH/
American Petro-Hunter Inc., Key Highlights
-AAPH has acquired working interests in quality oil and gas projects currently focusing on gas in California and oil in Kansas
-AAPH has drilled a successful commercial well on its first endeavor in Kansas.
-AAPH has aligned itself with prudent, experienced and effective oil and gas professionals as project operators.
-AAPH bases its acquisitions on a mix of acceptable risk, high reward and short payback in historically successful and productive regions.
-AAPH plans to "grow by the drill bit" in "our back yard" as we believe the US Domestic oil and gas market will continue to grow in the face of alternative energy which is deemed to be years from maturity.
-AAPH has the stated aim of becoming a 500 BOE producer within 18 months.
-AAPH plans to invest in projects with manageable participation expenditures so as to minimize share dilution.
-AAPH strives to build stakeholder value by prudent management that integrates a "shareholder first" philosophy.
-AAPH will be open, honest and transparent on all projects so as to ensure stakeholders receive accurate, up-to-date project information on a consistent basis
-AAPH will be a good corporate citizen, ensuring our operations meet or exceed all regulatory standards for the environment
-AAPH plans to continue the "hunt for petroleum" as it believes the answer to our reliance on foreign energy is "right next door."
United States Oil & Gas Corp (OTCQB: USOG)
Recent News: “United States Oil and Gas Corp is pleased to announce that as a result of its registration statement with the SEC becoming effective and remaining current in its required filings, its common shares are now trading on the OTC market for U.S. registered companies. The Company's ticker symbol, USOG, remains the same.”
Full Article: http://finance.yahoo.com/news/United-States-Oil-and-Gas-iw-3489930450.html?x=0&.v=1
About United States Oil & Gas Corp (OTCQB: USOG): United States Oil and Gas Corp is focused on acquiring and growing domestic oil and gas services companies. We target mid size family-run businesses with historically profitable results, strong balance sheets, high profit margins, and solid management teams in place. Our subsidiary, Turnbull, which had revenues of $14 million in 2009, was founded in 1965. We own all of the facilities and equipment used at our locations in Plainville, Utica, and Palco, Kansas. Our subsidiary, United, was founded in 2003, and sells and distributes refined oil and gas products including specialty racing fuels throughout North Dakota as well as regions of South Dakota and Montana. We own and operate a convenience store in Belcourt, and hold approximately six acres of developable land located in Bottineau, North Dakota.
Chevron Corp (NYSE:CVX)
About Chevron Corp (NYSE:CVX): Chevron is one of the world’s leading integrated energy companies, with subsidiaries that conduct business worldwide. The company’s success is driven by the ingenuity and commitment of its employees and their application of the most innovative technologies in the world. Chevron is involved in virtually every facet of the energy industry. The company explores for, produces and transports crude oil and natural gas; refines, markets and distributes transportation fuels and other energy products; manufactures and sells petrochemical products; generates power and produces geothermal energy; provides energy efficiency solutions; and develops the energy resources of the future; including bio-fuels. Chevron is based in San Ramon, Calif. More information about Chevron is available at www.chevron.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
About our Oil and Gas portal:
http://www.oilandgasstocksnews.com/ is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (three thousand per month). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on American Petro-hunter Inc (OTCBB: AAPH) contact the company IR directly.
For info on Investorideas.com
Contact:
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Sunday, October 10, 2010
Thursday, September 30, 2010
Today's Nanotechnology stock news from http://www.investorideas.com/
Investorideas.com updates its Nanotechnology investors for September 30th
Nanotechnology Stocks; mPhase (OTC.BB:XDSL) Smart NanoBattery Featured in September 2010 Issue of Medical Products Manufacturing News
mPhase has sights on Medical Applications
Read today's news on Nanotechnology stocks: http://www.investorideas.com/CO/XDSL/news/9301.asp
Want to research Nanotech stocks? Visit our Nanotechnology stocks portal
http://www.nanotechnologyinvestment.com/ and our nanotech stocks directory
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Investorideas.com updates its Nanotechnology investors for September 30th
Nanotechnology Stocks; mPhase (OTC.BB:XDSL) Smart NanoBattery Featured in September 2010 Issue of Medical Products Manufacturing News
mPhase has sights on Medical Applications
Read today's news on Nanotechnology stocks: http://www.investorideas.com/CO/XDSL/news/9301.asp
Want to research Nanotech stocks? Visit our Nanotechnology stocks portal
http://www.nanotechnologyinvestment.com/ and our nanotech stocks directory
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Monday, September 27, 2010
Investorideas.com - Biotech Stocks on the Move: High Volume Traders; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:SGEN), (NASDAQ:GENZ)
Investorideas.com - Biotech Stocks on the Move: High Volume Traders; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:SGEN), (NASDAQ:GENZ)
Visit this company: www.uvflutech.com
Point Roberts, WA - September 27, 2010 (Investorideas.com Newswire, www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research for investors, reports on recent Volume Leading Biotech/ Pharma Stocks news and trading for September 27th on the OTCBB and NASDAQ Markets. Top gainers included Seattle Genetics, Inc. (NASDAQ: SGEN), one of the most advanced stocks on the Nasdaq.com in morning trading.
(
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Seattle Genetics Inc (NASDAQ:SGEN), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), and Genzyme Corp. (NASDAQ:GENZ)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.34, up 0.02 (6.25%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2410, up 0.0229 (10.04%) on Volume of 13,387,394 shares
Seattle Genetics Inc. (NASDAQ: SGEN), trading at $14.91, up 2.75 (22.62%) on Volume of 7,333,439 shares
Genzyme Corp. (NASDAQ:GENZ) trading at $ 71.75, up 0.15 (0.21%)
Biotech Stocks to Watch; Recent News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
UV Flu Technologies, Inc., Key Highlights
FDA Approved as a Class II Medical device
Extensive testing by EPA and FDA certified laboratories confirm the proprietary system has over 99% effectiveness of eliminating bacteria
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, proprietary design, and FDA market clearance approving the sale of its products as medical devices.
The Company has been issued U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.
Experts have warned that a new type of drug-resistant superbug is emerging. NDM-1 is a gene carried by bacteria that makes the strain resistant to some of the most powerful antibiotics. NDM-1 can easily now jump from one strain of bacteria to another.
Latest News:
"UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households."
Full Article: http://finance.yahoo.com/news/UV-Flu-Technologies-to-Be-iw-1288158894.html?x=0&.v=1
Website: http://www.uvflutech.com/
Seattle Genetics Inc (NASDAQ:SGEN)
Seattle Genetics Inc (NASDAQ:SGEN) Recent News: “Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502 - News), today announced positive top-line results from the pivotal trial of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
Seventy-five percent of patients in the pivotal trial achieved an objective response as assessed by an independent central review, the primary endpoint of the trial. The median duration of response was greater than six months. The safety profile of brentuximab vedotin in this trial was generally consistent with prior clinical trial experience. A more complete data set will be presented at an upcoming scientific meeting."
Full News http://www.investorideas.com/news/9273.asp
About Seattle Genetics Inc (NASDAQ:SGEN):
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company’s lead product candidate, brentuximab vedotin, is being evaluated in a variety of lymphoma treatment settings including the relapsed and refractory Hodgkin lymphoma indication for which top-line pivotal data have been reported. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) and SGN-70. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at www.seattlegenetics.com.
Market Snapshot: (at time of release)
Dow 10,832.48 -27.78 -0.26% Nasdaq 2,372.96 -8.26 -0.35% S&P 500 1,144.53 -4.14 -0.36% 10 Yr Bond (%) 2.5300% -0.8200 Oil 75.68 -0.81 -1.06% Gold 1,297.00 +1.00 +0.08%
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Visit this company: www.uvflutech.com
Point Roberts, WA - September 27, 2010 (Investorideas.com Newswire, www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research for investors, reports on recent Volume Leading Biotech/ Pharma Stocks news and trading for September 27th on the OTCBB and NASDAQ Markets. Top gainers included Seattle Genetics, Inc. (NASDAQ: SGEN), one of the most advanced stocks on the Nasdaq.com in morning trading.
(
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Seattle Genetics Inc (NASDAQ:SGEN), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), and Genzyme Corp. (NASDAQ:GENZ)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.34, up 0.02 (6.25%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2410, up 0.0229 (10.04%) on Volume of 13,387,394 shares
Seattle Genetics Inc. (NASDAQ: SGEN), trading at $14.91, up 2.75 (22.62%) on Volume of 7,333,439 shares
Genzyme Corp. (NASDAQ:GENZ) trading at $ 71.75, up 0.15 (0.21%)
Biotech Stocks to Watch; Recent News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
UV Flu Technologies, Inc., Key Highlights
FDA Approved as a Class II Medical device
Extensive testing by EPA and FDA certified laboratories confirm the proprietary system has over 99% effectiveness of eliminating bacteria
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, proprietary design, and FDA market clearance approving the sale of its products as medical devices.
The Company has been issued U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.
Experts have warned that a new type of drug-resistant superbug is emerging. NDM-1 is a gene carried by bacteria that makes the strain resistant to some of the most powerful antibiotics. NDM-1 can easily now jump from one strain of bacteria to another.
Latest News:
"UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households."
Full Article: http://finance.yahoo.com/news/UV-Flu-Technologies-to-Be-iw-1288158894.html?x=0&.v=1
Website: http://www.uvflutech.com/
Seattle Genetics Inc (NASDAQ:SGEN)
Seattle Genetics Inc (NASDAQ:SGEN) Recent News: “Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502 - News), today announced positive top-line results from the pivotal trial of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
Seventy-five percent of patients in the pivotal trial achieved an objective response as assessed by an independent central review, the primary endpoint of the trial. The median duration of response was greater than six months. The safety profile of brentuximab vedotin in this trial was generally consistent with prior clinical trial experience. A more complete data set will be presented at an upcoming scientific meeting."
Full News http://www.investorideas.com/news/9273.asp
About Seattle Genetics Inc (NASDAQ:SGEN):
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company’s lead product candidate, brentuximab vedotin, is being evaluated in a variety of lymphoma treatment settings including the relapsed and refractory Hodgkin lymphoma indication for which top-line pivotal data have been reported. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) and SGN-70. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at www.seattlegenetics.com.
Market Snapshot: (at time of release)
Dow 10,832.48 -27.78 -0.26% Nasdaq 2,372.96 -8.26 -0.35% S&P 500 1,144.53 -4.14 -0.36% 10 Yr Bond (%) 2.5300% -0.8200 Oil 75.68 -0.81 -1.06% Gold 1,297.00 +1.00 +0.08%
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Investorideas.com - Biotech Stock Alert; (OTCBB: UVFT) Reports Air Purifier Technology Fights Superbugs NDM-1
Visit this company: http://www.uvflutech.com/
CENTERVILLE, MA - September 27, 2010 (Investorideas.com newswire, http://www.biotechindustrystocks.com/ ) – Biotechnology Company News- UV Flu Technologies, Inc. ( OTC.BB:UVFT ) recently announced news that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.John J. Lennon, President & CEO
Contact:Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838
Published at Investorideas.com and http://www.biotechindustrystocks.com/
Related industry commentary:
According to a recent article in Stltoday.com "The only antibiotics shown to work against NDM-1 are older-generation drugs that can have toxic side effects on a patient's kidneys. The drugs apparently work against the infections because they have not been circulating in the population for decades.Infection experts say new antibiotics are desperately needed to combat the growing field of superbugs.The Infectious Diseases Society of America has launched a "bad bugs need drugs" campaign to promote the development of 10 new antibiotics by 2020. The closest new antibiotic in development is still at least 18 months away from the market, Moenster said." Source: http://www.stltoday.com/lifestyles/health-med-fit/fitness/article_d0e57e62-22dc-55c7-96e1-300a858994f6.html
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at http://www.investorideas.com/ - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Visit this company: http://www.uvflutech.com/
CENTERVILLE, MA - September 27, 2010 (Investorideas.com newswire, http://www.biotechindustrystocks.com/ ) – Biotechnology Company News- UV Flu Technologies, Inc. ( OTC.BB:UVFT ) recently announced news that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.John J. Lennon, President & CEO
Contact:Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838
Published at Investorideas.com and http://www.biotechindustrystocks.com/
Related industry commentary:
According to a recent article in Stltoday.com "The only antibiotics shown to work against NDM-1 are older-generation drugs that can have toxic side effects on a patient's kidneys. The drugs apparently work against the infections because they have not been circulating in the population for decades.Infection experts say new antibiotics are desperately needed to combat the growing field of superbugs.The Infectious Diseases Society of America has launched a "bad bugs need drugs" campaign to promote the development of 10 new antibiotics by 2020. The closest new antibiotic in development is still at least 18 months away from the market, Moenster said." Source: http://www.stltoday.com/lifestyles/health-med-fit/fitness/article_d0e57e62-22dc-55c7-96e1-300a858994f6.html
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at http://www.investorideas.com/ - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory
Friday, September 24, 2010
Investorideas.com - Biotechnology Products; UV Flu Technologies (OTC.BB: UVFT) UV-400 Air Purifier Fights Superbugs including NDM-1
Investorideas.com - Biotechnology Products; UV Flu Technologies (OTC.BB: UVFT) UV-400 Air Purifier Fights Superbugs including NDM-1
"Superbugs may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant"- Dr. Wladyslaw Jan Kowalski, PE, Phd
Category: Investment, Biotech
Visit this company: www.uvflutech.com
CENTERVILLE, MA - September 24, 2010 (Investorideas.com newswire) - UV Flu Technologies, Inc. (OTC.BB:UVFT) reports that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
"Superbugs may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant"- Dr. Wladyslaw Jan Kowalski, PE, Phd
Category: Investment, Biotech
Visit this company: www.uvflutech.com
CENTERVILLE, MA - September 24, 2010 (Investorideas.com newswire) - UV Flu Technologies, Inc. (OTC.BB:UVFT) reports that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
Dr. Wladyslaw Jan Kowalski, PE, Phd, a world leading expert on the bacteria killing efficacy of ultraviolet light, recently commented on the UV-400: "Ultraviolet germicidal irradiation (UVGI) destroys bacteria by damaging the nucleic acids and thereby preventing reproduction. Multidrug-resistant microbes (superbugs) may have resistance to antibiotics but they remain as susceptible to ultraviolet radiation as any normal bacteria variant. The number of multidrug resistant microbes has been increasing, apparently due to overuse of antibiotics and other factors, and is expected to pose a serious challenge to health care facilities in the future as treatment options diminish."
Dr. Kowalski further added, "The ViraTech UV-400 model air cleaner has a demonstrated ability to disinfect air and inactivate a wide range of bacterial pathogens including Staphylococcus aureus (MRSA), Pseudomonas, and Klebsiella as has been conclusively demonstrated in independent laboratory tests. The UV-400 produces a germicidal UV exposure dose of 41 J/m(2), as independently verified by biodosimetric testing, which is sufficient to reduce pathogenic bacterial populations by at least 99%. This disinfection rate will apply regardless of the multidrug resistance of bacteria such as those that may contain the NDM-1 enzyme (the superbug gene). The ViraTech UV-400 unit provides a viable option for health care facilities struggling to cope with the growing problem of multidrug resistant organisms and this technology can serve as an adjunct to existing infection management procedures and disinfection protocols wherever the potential exists for microorganisms to spread by the airborne route."
"Our Company receives reports from around the world on an almost daily basis about the growing problems connected with the spread of these increasingly drug resistant bacterial strains," said Jack Lennon, President of UV Flu Technologies. "Antibiotics have become so pervasive in today's medical therapies, that not only are they becoming less effective, but their overuse is increasingly being considered as part of the problem. Drug-resistant superbugs have now been found in 20 states, as well as worldwide, and when they hit the critically ill, they can be fatal 30-60% of the time. In one recent incident at an infant ward at the University College Hospital in London, 15 babies in the unit were found to be carrying several types of bacteria, including 13 who had bacterial superbugs resistant to treatment. Of four babies seriously infected, one survived."
"So that the public can participate in actions to help reduce the spread of these strains, the Company has committed to advertising, including television and other media in order to educate consumers and to offer help where needed," said Mr. Lennon. "We are looking to develop a plan to offer our UV-400 indoor air quality units either free or at significantly discounted costs to those schools and hospitals that suffer from serious outbreaks. We hope to partner with institutions which are genuinely interested in working with us in order to develop an action plan for their facilities. For those with respiratory problems or weakened immune systems, hospital or institution acquired bacterial infections can prove deadly. We believe our product delivers an immediate, effective and proven ability to kill at least 99% of airborne bacteria thereby reducing the risk of infection."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Investorideas.com - Biotech News: UV Flu Technologies (OTCBB: UVFT) Air Purification System Airing on "The Designing Spaces/ Holiday Spaces" TV Show
Investorideas.com - Biotech News: UV Flu Technologies (OTCBB: UVFT) Air Purification System Airing on "The Designing Spaces/ Holiday Spaces" TV Show
Show expects to reach up to 75 million households
Category: Investment, Biotech
Subscribe to Investor Ideas Newswire
Visit this company: www.uvflutech.com
CENTERVILLE, MA – September 24, 2010 (Investorideas.com Newswire) - Biotechnology Products company, UV Flu Technologies, Inc. (OTCBB: UVFT) reports the company's UV-400 air purification system will be featured on a segment of the "Designing Spaces" TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women's Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.
"We are thrilled to be working with Designing Spaces as part of this Holiday Show," said Jack Lennon, President of UV Flu Technologies. "The theme of the segment will be how to stay healthy indoors over the holidays, and our product fits perfectly within this theme. Our ViraTech UV-400, has been laboratory proven to kill airborne bacteria and other contaminants, including odors and volatile organic compounds. There are hundreds of compounds, such as formaldehyde, acetone, benzene, etc… that can be found in the average home and which can cause severe respiratory problems."
Mr. Lennon further stated "These compounds are regularly found in furniture, cleaning supplies, building materials, insecticides, and even common household items like hairspray. With families spending over 90% of their time indoors, particularly with the proliferation of indoor home theaters and computer games, the public is susceptible to increased risks of exposure or transmission of serious illnesses during the holidays. We hope to educate people to the many dangers associated with poor indoor air quality, and that our UV-400 is a very cost-effective ways to protect themselves. We believe this show will provide a tremendous platform to reach one of our key target markets; parents concerned with the health of their families."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.John J. Lennon, President & CEO
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Show expects to reach up to 75 million households
Category: Investment, Biotech
Subscribe to Investor Ideas Newswire
Visit this company: www.uvflutech.com
CENTERVILLE, MA – September 24, 2010 (Investorideas.com Newswire) - Biotechnology Products company, UV Flu Technologies, Inc. (OTCBB: UVFT) reports the company's UV-400 air purification system will be featured on a segment of the "Designing Spaces" TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women's Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.
"We are thrilled to be working with Designing Spaces as part of this Holiday Show," said Jack Lennon, President of UV Flu Technologies. "The theme of the segment will be how to stay healthy indoors over the holidays, and our product fits perfectly within this theme. Our ViraTech UV-400, has been laboratory proven to kill airborne bacteria and other contaminants, including odors and volatile organic compounds. There are hundreds of compounds, such as formaldehyde, acetone, benzene, etc… that can be found in the average home and which can cause severe respiratory problems."
Mr. Lennon further stated "These compounds are regularly found in furniture, cleaning supplies, building materials, insecticides, and even common household items like hairspray. With families spending over 90% of their time indoors, particularly with the proliferation of indoor home theaters and computer games, the public is susceptible to increased risks of exposure or transmission of serious illnesses during the holidays. We hope to educate people to the many dangers associated with poor indoor air quality, and that our UV-400 is a very cost-effective ways to protect themselves. We believe this show will provide a tremendous platform to reach one of our key target markets; parents concerned with the health of their families."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.John J. Lennon, President & CEO
Investor Information:Geaux IR Services, Inc.Toll-Free: 1-888-355-8838investors@uvflutech.com
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Connect with Investorideas.com
Publish Your News - Send a release
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Investorideas.com - Trading Alert: Biotech Stocks To Watch; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:AMGN), (NYSE:ELN)
Investorideas.com - Trading Alert: Biotech Stocks To Watch; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:AMGN), (NYSE:ELN)
Visit these companies: www.uvflutech.com and www.kraiglabs.com
Point Roberts, WA - September 24, 2010 (Investorideas.com Newswire) - InvestorIdeas.com, leader in sector research for investors, reports on recent Biotech/ Healthcare Stocks news and trading for September 24th.
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), Amgen Inc. (NASDAQ:AMGM), and Elan Corp. plc (NYSE: ELN)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.31, up 0.01 (3.33%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2145, up 0.0630 (41.58%) on Volume of 20,704,335 shares
Amgen Inc. (NASDAQ:AMGN), trading at $ 56.10, up 0.38 (0.68%)
Elan Corp. plc NYSE:ELN) trading at $ 5.42, up 0.30 (5.86%)
Biotech Stocks to Watch News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
The U.S. CDC has described antibiotic resistance as “one of the world’s most pressing health problems” as “the number of bacteria resistant to antibiotics has increased in the last decade [and] … many bacterial infections are becoming resistant to the most commonly prescribed antibiotic treatments.” The World Health Organization (WHO) has identified antibiotic resistance as “one of the three greatest threats to human health.” Source: http://www.idsociety.org/10x20.htm
Latest News:
“UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.”
Full Article:Website: http://www.uvflutech.com/
UV Flu Technologies, Inc., Key Highlights
FDA Approved as a Class II Medical device
Extensive testing by EPA and FDA certified laboratories confirm the proprietary system has over 99% effectiveness of eliminating bacteria
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, proprietary design, and FDA market clearance approving the sale of its products as medical devices.
The Company has been issued U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.
Experts have warned that a new type of drug-resistant superbug is emerging. NDM-1 is a gene carried by bacteria that makes the strain resistant to some of the most powerful antibiotics. NDM-1 can easily now jump from one strain of bacteria to another.
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) Recent News: : “Kraig Biocraft Laboratories, Inc. is very pleased to announce that the University of Notre Dame and Kraig Biocraft Laboratories will hold a joint press conference Wednesday, September 29, 2010 on the Notre Dame campus to describe a new research breakthrough and its possible biomedical and commercial applications.”
Full Article: http://finance.yahoo.com/news/University-of-Notre-Dame-and-iw-1958169015.html?x=0&.v=1
About Kraig Biocraft Laboratories, Inc: is a biotechnology company focused on the development of commercially significant high performance polymers and technical fiber. Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials including spider silk. Our work is focused on the development of spider silk and other high strength polymers that we believe have the potential for significant industrial and consumer applications. http://www.kraiglabs.com/
Market Snapshot: (at time of release)
Dow 10,865.10 +202.68 +1.90% Nasdaq 2,378.20 +51.12 +2.20% S&P 500 1,148.57 +23.74 +2.11% 10 Yr Bond(%) 2.6100% +0.5500 Oil 76.42 +1.24 +1.65% Gold 1,295.40 +1.10 +0.08%
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Visit these companies: www.uvflutech.com and www.kraiglabs.com
Point Roberts, WA - September 24, 2010 (Investorideas.com Newswire) - InvestorIdeas.com, leader in sector research for investors, reports on recent Biotech/ Healthcare Stocks news and trading for September 24th.
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), Amgen Inc. (NASDAQ:AMGM), and Elan Corp. plc (NYSE: ELN)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.31, up 0.01 (3.33%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2145, up 0.0630 (41.58%) on Volume of 20,704,335 shares
Amgen Inc. (NASDAQ:AMGN), trading at $ 56.10, up 0.38 (0.68%)
Elan Corp. plc NYSE:ELN) trading at $ 5.42, up 0.30 (5.86%)
Biotech Stocks to Watch News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
The U.S. CDC has described antibiotic resistance as “one of the world’s most pressing health problems” as “the number of bacteria resistant to antibiotics has increased in the last decade [and] … many bacterial infections are becoming resistant to the most commonly prescribed antibiotic treatments.” The World Health Organization (WHO) has identified antibiotic resistance as “one of the three greatest threats to human health.” Source: http://www.idsociety.org/10x20.htm
Latest News:
“UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.”
Full Article:Website: http://www.uvflutech.com/
UV Flu Technologies, Inc., Key Highlights
FDA Approved as a Class II Medical device
Extensive testing by EPA and FDA certified laboratories confirm the proprietary system has over 99% effectiveness of eliminating bacteria
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, proprietary design, and FDA market clearance approving the sale of its products as medical devices.
The Company has been issued U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.
Experts have warned that a new type of drug-resistant superbug is emerging. NDM-1 is a gene carried by bacteria that makes the strain resistant to some of the most powerful antibiotics. NDM-1 can easily now jump from one strain of bacteria to another.
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) Recent News: : “Kraig Biocraft Laboratories, Inc. is very pleased to announce that the University of Notre Dame and Kraig Biocraft Laboratories will hold a joint press conference Wednesday, September 29, 2010 on the Notre Dame campus to describe a new research breakthrough and its possible biomedical and commercial applications.”
Full Article: http://finance.yahoo.com/news/University-of-Notre-Dame-and-iw-1958169015.html?x=0&.v=1
About Kraig Biocraft Laboratories, Inc: is a biotechnology company focused on the development of commercially significant high performance polymers and technical fiber. Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials including spider silk. Our work is focused on the development of spider silk and other high strength polymers that we believe have the potential for significant industrial and consumer applications. http://www.kraiglabs.com/
Market Snapshot: (at time of release)
Dow 10,865.10 +202.68 +1.90% Nasdaq 2,378.20 +51.12 +2.20% S&P 500 1,148.57 +23.74 +2.11% 10 Yr Bond(%) 2.6100% +0.5500 Oil 76.42 +1.24 +1.65% Gold 1,295.40 +1.10 +0.08%
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Tuesday, September 21, 2010
Investorideas.com - Agriculture Stocks Trading in the Green; (OTCBB: AQUM), (NYSE: MOS), (NasdaqCM: COIN), (NYSE: POT)
Potash (NYSE: POT) trading at $148.49, up $1.21
Share this news:
Visit this company: http://www.urbanagcorp.com/
September 20, 2010 – www.InvestorIdeas.com, a leader in sector research for independent investor’s reports on Agriculture stocks trading for Sept 20, 2010. As the Dow and NASDAQ see gains on the day, the agriculture stock sector sees green.
Sector Snapshot – Agriculture Stocks Trading September 20th
Aquamer Medical Corp. (OTCBB: AQUM) (DBA/ Urban Agricultural Corp.) trading at $0.11
Agrium Inc. Common Stock (NYSE: AGU) trading at $75.41, up 0.79 (1.06%) 2:29PM EDT
China Green Agriculture, Inc. C (NYSE: CGA) trading at $8.88, up 0.19 (2.19%) 2:11PM EDT
Converted Organics Inc. (NasdaqCM: COIN) trading at$ 0.4071, up 0.0011 (0.27%)
Mosaic Company (NYSE: MOS) trading at $61.41, up 1.39 (2.32%) 2:24PM EDT
Origin Agritech Limited (SEED) trading at $7.53, up 0.08 (1.07%) 2:41PM EDT
Market Vectors Agribusiness ETF (NYSEArca: MOO) trading at 47.34, up 0.58 (1.24%) 2:21PM EDT
Potash Corporation of Saskatche (NYSE: POT) trading at $148.49, up $1.21 (0.82%) 2:29PM EDT
To research more agriculture stocks, visit the agriculture stocks directory at Investorideas.com.
Showcase green agriculture stock company profile:
Aquamer Medical Corp. (OTCBB: AQUM) (DBA/ Urban Agricultural Corp.) a sustainable agriculture stock recently announced the acquisition of Urban Agricultural Corp.
("Urban Ag"), a privately owned company.
(OTCBB: AQUM) Senior management discuss recent initiatives at NASDAQ Marketsite, Times Square, NYC / August 19, 2010http://vimeo.com/14487897
The company is entering the business of urban indoor farming, environmentally friendly and sustainable urban production of healthy agricultural products under highly controlled, indoor conditions using advanced techniques and processes.Investors can view the full company profile at: http://www.investorideas.com/CO/AQUM/
See video on Youtube.com: Vertical Farming; Nick Brusatore, TERRASPHEREhttp://youtu.be/WBBaO3jL0gc
To get more info on the company visit the company website: Website: http://www.urbanagcorp.com/And call the IR contacts at the company.
Visit our showcase green stocks and research green stocks at: http://www.renewableenergystocks.com/ and http://www.investorideas.com/GI/
About Our Green Investor content:
http://www.investorideas.com/ was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit the Investorideas.com Green Investor Portals and pages: http://www.investorideas.com/GI/, http://www.renewableenergystocks.com/, http://www.fuelcellcarnews.com/, http://www.environmentstocks.com/ And http://www.water-stocks.com/
Get free investor newsletters and stock alerts
Disclaimer/ Disclosure: OTCBB: AQUM is a paid advertising client on Investorideas.com – five thousand per month plus 31500 restricted shares for 2 months. Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more www.InvestorIdeas.com/About/Disclaimer.asp, http://www.investorideas.com/About/News/Clientspecifics.asp
For More info on Investor ideas contact:
800.665.0411Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Source – Investorideas.com
Potash (NYSE: POT) trading at $148.49, up $1.21
Share this news:
Visit this company: http://www.urbanagcorp.com/
September 20, 2010 – www.InvestorIdeas.com, a leader in sector research for independent investor’s reports on Agriculture stocks trading for Sept 20, 2010. As the Dow and NASDAQ see gains on the day, the agriculture stock sector sees green.
Sector Snapshot – Agriculture Stocks Trading September 20th
Aquamer Medical Corp. (OTCBB: AQUM) (DBA/ Urban Agricultural Corp.) trading at $0.11
Agrium Inc. Common Stock (NYSE: AGU) trading at $75.41, up 0.79 (1.06%) 2:29PM EDT
China Green Agriculture, Inc. C (NYSE: CGA) trading at $8.88, up 0.19 (2.19%) 2:11PM EDT
Converted Organics Inc. (NasdaqCM: COIN) trading at$ 0.4071, up 0.0011 (0.27%)
Mosaic Company (NYSE: MOS) trading at $61.41, up 1.39 (2.32%) 2:24PM EDT
Origin Agritech Limited (SEED) trading at $7.53, up 0.08 (1.07%) 2:41PM EDT
Market Vectors Agribusiness ETF (NYSEArca: MOO) trading at 47.34, up 0.58 (1.24%) 2:21PM EDT
Potash Corporation of Saskatche (NYSE: POT) trading at $148.49, up $1.21 (0.82%) 2:29PM EDT
To research more agriculture stocks, visit the agriculture stocks directory at Investorideas.com.
Showcase green agriculture stock company profile:
Aquamer Medical Corp. (OTCBB: AQUM) (DBA/ Urban Agricultural Corp.) a sustainable agriculture stock recently announced the acquisition of Urban Agricultural Corp.
("Urban Ag"), a privately owned company.
(OTCBB: AQUM) Senior management discuss recent initiatives at NASDAQ Marketsite, Times Square, NYC / August 19, 2010http://vimeo.com/14487897
The company is entering the business of urban indoor farming, environmentally friendly and sustainable urban production of healthy agricultural products under highly controlled, indoor conditions using advanced techniques and processes.Investors can view the full company profile at: http://www.investorideas.com/CO/AQUM/
See video on Youtube.com: Vertical Farming; Nick Brusatore, TERRASPHEREhttp://youtu.be/WBBaO3jL0gc
To get more info on the company visit the company website: Website: http://www.urbanagcorp.com/And call the IR contacts at the company.
Visit our showcase green stocks and research green stocks at: http://www.renewableenergystocks.com/ and http://www.investorideas.com/GI/
About Our Green Investor content:
http://www.investorideas.com/ was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit the Investorideas.com Green Investor Portals and pages: http://www.investorideas.com/GI/, http://www.renewableenergystocks.com/, http://www.fuelcellcarnews.com/, http://www.environmentstocks.com/ And http://www.water-stocks.com/
Get free investor newsletters and stock alerts
Disclaimer/ Disclosure: OTCBB: AQUM is a paid advertising client on Investorideas.com – five thousand per month plus 31500 restricted shares for 2 months. Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more www.InvestorIdeas.com/About/Disclaimer.asp, http://www.investorideas.com/About/News/Clientspecifics.asp
For More info on Investor ideas contact:
800.665.0411Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Source – Investorideas.com
Investorideas.com - Water Stocks News; Wescorp (OTCBB:WSCE) Updates 30-Day Operation of H2Omaxx Oil-Water Separation Technology at Cancen Oil
Investorideas.com - Water Stocks News; Wescorp (OTCBB:WSCE) Updates 30-Day Operation of H2Omaxx Oil-Water Separation Technology at Cancen Oil
New Data Expands H2Omaxx Performance Range - Effectively Reducing 40+% Contaminated Hydrocarbon Waste Water to Less than 12 Parts Per Million
Share this news:
Visit this company: www.wescorpenergy.com
CALGARY, ALBERTA - September 20, 2010 (Investorideas.com Water Stocks Newswire) - Wescorp Energy Inc. (OTC.BB:WSCE), a clean water technology company focused on implementing its low-cost solutions into several markets including the oil & gas and marine industries, provided an update today that the Company's H2Omaxx oil-water separation unit has completed its initial 30-day commercial operations at Cancen Oil Canada Corporation's New Sarepta facility. The Company has confirmed new operating capabilities for the H2Omaxx clean water technology; cleaning 40+% contaminated hydrocarbon waste water to less than 12 ppm oil.
Overview of 30 day operation – summary:
In July, Wescorp commenced a 30-day continuous commercial test of H2Omaxx to define a number of operating parameters, including heat requirements and treatment time.
The unit ran successfully and reliably, meeting Cancen's operational needs by treating approximately 3,500 barrels of contaminated fluid.
Unexpectedly, the fluid received was from oil sands operations, and was heavily contaminated with hydrocarbons. The oil/water mixture was in the range of 10-40% plus oil - contaminated. The H2Omaxx has historically treated oil/water mixture in the 3-5% range.
The H2Omaxx successfully treated the 40/60 mixture by cycling the fluid through the treatment process a number of times, rather than a single pass through which is normal for less contaminated fluid.
The batch treatment of the mixture achieved Cancen's standards for fluid disposal in its disposal well. While Wescorp was subject to the operational pressures of Cancen's site, Wescorp was permitted to undertake a multi-cycle treatment process of one tank of heavily contaminated fluid, under conditions which permit replication, in order to verify the operating range of the H2Omaxx.
Inlet and post-treatment outlet samples were taken. Lab results from ALS Laboratory Group establish that the H2Omaxx successfully received fluids contaminated at 40%+ (by volume) level, and discharged a cleaned fluid at less than 12 ppm hydrocarbons.
Treatment of this level of hydrocarbon contamination without extensive heat, chemicals or filters is, in Management's judgment, exceptional.
Wescorp believes that the next stage of testing should focus on defining what level of contamination requires only one treatment cycle, and what level of contamination requires repeated treatment cycles, also known as batch treatment.
"This 30-day operating period is important for several reasons," states Robert G. Power, Executive Chairman of Wescorp. "First, Wescorp's H2Omaxx technology has passed the research stage and we are now focusing on scalability and the range of hydrocarbon contamination to treat. Second, we have again proved the technology's operational reliability – a critical issue with many competing technologies.
"Third, we learned that the H2Omaxx can successfully treat fluids with a dramatically higher percentage of contaminates than historically treated. We believe that this expanded upper treatment range opens up significant new market potential.
"We caution readers that these results now need to be replicated in additional operating scenarios. The reality of oil field waste fluid treatments is that there is a wide range of hydrocarbon contamination and related chemical contamination. Further testing is required. However, these results demonstrate H2Omaxx's highly effective ability to clean some of the most contaminated waste in the oil industry without the use of filters, chemicals or heat."
H2Omaxx Technology
H2Omaxx has been proven to be a safe, effective, economical and environmentally friendly process for cleaning and separating oil and solids from water.
Using Wescorp's nano-aeration technology, previous independent test results have shown the H2Omaxx technology to reduce the oil content in produced water to less than 10 parts per million without the use of chemicals, filters or heat.
Use of H2Omaxx provides important cost benefits to the operator when compared with the traditional multi-technology approach to remediate water.
H2Omaxx can lower both the operator's capital costs and operating costs significantly. In addition, new revenues are created by the capture of barrels of oil that would otherwise be disposed.
The H2Omaxx technology has been designed to produce the H2Omaxx unit in a variety of sizes, including a mobile unit and commercial units (2,500, 10,000 and 65,000 barrels-per-day).
10,000 BPD Mobile Unit
Wescorp previously announced that it will be taking delivery of a new 10,000 barrel-per-day H2Omaxx unit, designed and built by K-Line Trailers Ltd. (www.klinetrailers.com). Because delivery of a component is not expected to be received by K-Line until mid October, Wescorp presently expects to receive the completed unit by early November. After completion of the commissioning phase, the mobile unit, which is designed to be rapidly transported to remote locations, will be available to be marketed for potential customer sites, initially in Western Canada. Wescorp also intends to market the unit's services in the Gulf of Mexico area.
The mobile, 10,000 barrel-per-day unit is designed to be placed swiftly on sites for the purposes of demonstrating the technology and for use for short-term commercial operations. The unit will have its own storage, separation and containment tanks, micro-aeration generators, and firmware and computer automation technology to allow water remediation with minimal human supervision.
About Wescorp
Wescorp Energy Inc. (www.wescorpenergy.com) is a clean water solutions company focused on implementing its superior yet low cost solutions into the oil and gas production industry.
Safe Harbor Statement
Any statements contained herein that are not historical facts may be forward-looking statements, and involve risks and uncertainties. Potential factors could cause actual results to differ materially from those expressed or implied by such statements. Information on the potential factors that could affect the Company's actual results of operations is included in its filings with the Securities and Exchange Commission. These risks may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the Securities and Exchange Commission in the future.
Investor Relations Contact:
Bibicoff + MacInnis, Inc.Terri MacInnis, Dir. of Investor Relations818-379-8500terri@bibimac.com
Visit the WSCE showcase profile at Investorideas.com Request News and Info on WSCE
More Info: Turn to a leader for investing in waterInvestorideas.com and www.water-stocks.comResearch Global Water StocksVisit our Water Stocks Directory
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Disclosure, Disclaimer/ WSCE is a paid advertising client on Investorideas.com and our water and renewable-energy portals (twenty five hundred from 3rd party plus stock options at .25)
New Data Expands H2Omaxx Performance Range - Effectively Reducing 40+% Contaminated Hydrocarbon Waste Water to Less than 12 Parts Per Million
Share this news:
Visit this company: www.wescorpenergy.com
CALGARY, ALBERTA - September 20, 2010 (Investorideas.com Water Stocks Newswire) - Wescorp Energy Inc. (OTC.BB:WSCE), a clean water technology company focused on implementing its low-cost solutions into several markets including the oil & gas and marine industries, provided an update today that the Company's H2Omaxx oil-water separation unit has completed its initial 30-day commercial operations at Cancen Oil Canada Corporation's New Sarepta facility. The Company has confirmed new operating capabilities for the H2Omaxx clean water technology; cleaning 40+% contaminated hydrocarbon waste water to less than 12 ppm oil.
Overview of 30 day operation – summary:
In July, Wescorp commenced a 30-day continuous commercial test of H2Omaxx to define a number of operating parameters, including heat requirements and treatment time.
The unit ran successfully and reliably, meeting Cancen's operational needs by treating approximately 3,500 barrels of contaminated fluid.
Unexpectedly, the fluid received was from oil sands operations, and was heavily contaminated with hydrocarbons. The oil/water mixture was in the range of 10-40% plus oil - contaminated. The H2Omaxx has historically treated oil/water mixture in the 3-5% range.
The H2Omaxx successfully treated the 40/60 mixture by cycling the fluid through the treatment process a number of times, rather than a single pass through which is normal for less contaminated fluid.
The batch treatment of the mixture achieved Cancen's standards for fluid disposal in its disposal well. While Wescorp was subject to the operational pressures of Cancen's site, Wescorp was permitted to undertake a multi-cycle treatment process of one tank of heavily contaminated fluid, under conditions which permit replication, in order to verify the operating range of the H2Omaxx.
Inlet and post-treatment outlet samples were taken. Lab results from ALS Laboratory Group establish that the H2Omaxx successfully received fluids contaminated at 40%+ (by volume) level, and discharged a cleaned fluid at less than 12 ppm hydrocarbons.
Treatment of this level of hydrocarbon contamination without extensive heat, chemicals or filters is, in Management's judgment, exceptional.
Wescorp believes that the next stage of testing should focus on defining what level of contamination requires only one treatment cycle, and what level of contamination requires repeated treatment cycles, also known as batch treatment.
"This 30-day operating period is important for several reasons," states Robert G. Power, Executive Chairman of Wescorp. "First, Wescorp's H2Omaxx technology has passed the research stage and we are now focusing on scalability and the range of hydrocarbon contamination to treat. Second, we have again proved the technology's operational reliability – a critical issue with many competing technologies.
"Third, we learned that the H2Omaxx can successfully treat fluids with a dramatically higher percentage of contaminates than historically treated. We believe that this expanded upper treatment range opens up significant new market potential.
"We caution readers that these results now need to be replicated in additional operating scenarios. The reality of oil field waste fluid treatments is that there is a wide range of hydrocarbon contamination and related chemical contamination. Further testing is required. However, these results demonstrate H2Omaxx's highly effective ability to clean some of the most contaminated waste in the oil industry without the use of filters, chemicals or heat."
H2Omaxx Technology
H2Omaxx has been proven to be a safe, effective, economical and environmentally friendly process for cleaning and separating oil and solids from water.
Using Wescorp's nano-aeration technology, previous independent test results have shown the H2Omaxx technology to reduce the oil content in produced water to less than 10 parts per million without the use of chemicals, filters or heat.
Use of H2Omaxx provides important cost benefits to the operator when compared with the traditional multi-technology approach to remediate water.
H2Omaxx can lower both the operator's capital costs and operating costs significantly. In addition, new revenues are created by the capture of barrels of oil that would otherwise be disposed.
The H2Omaxx technology has been designed to produce the H2Omaxx unit in a variety of sizes, including a mobile unit and commercial units (2,500, 10,000 and 65,000 barrels-per-day).
10,000 BPD Mobile Unit
Wescorp previously announced that it will be taking delivery of a new 10,000 barrel-per-day H2Omaxx unit, designed and built by K-Line Trailers Ltd. (www.klinetrailers.com). Because delivery of a component is not expected to be received by K-Line until mid October, Wescorp presently expects to receive the completed unit by early November. After completion of the commissioning phase, the mobile unit, which is designed to be rapidly transported to remote locations, will be available to be marketed for potential customer sites, initially in Western Canada. Wescorp also intends to market the unit's services in the Gulf of Mexico area.
The mobile, 10,000 barrel-per-day unit is designed to be placed swiftly on sites for the purposes of demonstrating the technology and for use for short-term commercial operations. The unit will have its own storage, separation and containment tanks, micro-aeration generators, and firmware and computer automation technology to allow water remediation with minimal human supervision.
About Wescorp
Wescorp Energy Inc. (www.wescorpenergy.com) is a clean water solutions company focused on implementing its superior yet low cost solutions into the oil and gas production industry.
Safe Harbor Statement
Any statements contained herein that are not historical facts may be forward-looking statements, and involve risks and uncertainties. Potential factors could cause actual results to differ materially from those expressed or implied by such statements. Information on the potential factors that could affect the Company's actual results of operations is included in its filings with the Securities and Exchange Commission. These risks may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the Securities and Exchange Commission in the future.
Investor Relations Contact:
Bibicoff + MacInnis, Inc.Terri MacInnis, Dir. of Investor Relations818-379-8500terri@bibimac.com
Visit the WSCE showcase profile at Investorideas.com Request News and Info on WSCE
More Info: Turn to a leader for investing in waterInvestorideas.com and www.water-stocks.comResearch Global Water StocksVisit our Water Stocks Directory
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Disclosure, Disclaimer/ WSCE is a paid advertising client on Investorideas.com and our water and renewable-energy portals (twenty five hundred from 3rd party plus stock options at .25)
Investorideas.com - Tech Stocks; eLayaway, Inc. (OTCBB:ELAY) Announces Contract Renewal With Merchant Retailer Venue
Investorideas.com - Tech Stocks; eLayaway, Inc. (OTCBB:ELAY) Announces Contract Renewal With Merchant Retailer Venue
Visit this company: www.eLayaway.com
TALLAHASSEE, Fla. - September 21, 2010 (Investorideas.com newswire) – eLayaway, Inc. (OTCBB:ELAY), the Internet's first and only patent pending layaway payment processor, today announced that merchant retailer Venue(R) has renewed its contract with the Company to continue use of the highly effective eLayaway(R) payment processing system. Venue is a privately-held online merchant and direct retailer of brand-name consumer products that conducts business and sells its products to the public via its popular Venue.com website. For over the past year, Venue has partnered with eLayaway, Inc. to establish Venue.com's user-friendly online payment option called Venue Layaway, a privately-labeled layaway alternative powered by eLayaway(R).
Since implementing the eLayaway(R) payment system under its Venue Layaway private label in June 2009, Venue.com has become a highly satisfied user and advocate of the eLayaway(R) payment system. According to Robert Malina, President of Venue.com, "There was no question we were going to renew our highly successful partnership with eLayaway, Inc. in 2010. Since offering our customers the Venue Layaway payment option, powered by eLayaway(R), our company has benefited by capturing sales that otherwise may not have been possible due to consumer credit challenges." He continued, "Working with eLayaway(R) has been great as they understand our business model, our customers and how we can work together to drive sales while providing customers with access to the items they want from our product line. It's a win-win situation and we see no end in sight for our relationship with eLayaway(R)."
For many online merchants, eLayaway(R) offers an opportunity to affordably provide a layaway payment option to their customers as a means to expand market share while reducing the administrative requirements of traditional layaway, goals that are particularly important in this economic environment in which most merchants are seeking ways to increase sales while consumers are cutting back on their spending habits.
Sergio Pinon, Founder and Chief Marketing Officer of eLayaway, Inc., advised, "The reason we created eLayaway(R) was to assist merchants in successfully reaching their financial objectives while providing their customers with much appreciated, effective payment options that enable them to buy the goods and services they desire. We are very excited to be part of Venue's success, and to be featured prominently on the Venue.com home page under the Shopping section with its private label name, Venue Layaway. We look forward to continuing our relationship with this important client in 2011 and going forward."
How eLayaway Works for Consumers
eLayaway(R) is an online payment system that allows consumers to pay for the products and services they desire using manageable periodic payments, thereby making purchases affordable and easy to budget. Payments are automatically drafted from the consumer's designated bank account via Automated Clearing House ("ACH") on the modifiable schedule set by the consumer at the time of purchase. A flat 1.9% transaction fee is charged to the consumer and all payments are held in an account in trust at HSBC Bank and transferred to the merchant once full payment has been made. Like traditional layaway programs of the past, delivery of the product or service occurs once payment is complete. Payment processing and supporting services are handled by eLayaway(R) while merchants provide order fulfillment.
How eLayaway Works for Merchants
For many online merchants, eLayaway(R) offers an opportunity to provide layaway to their customers as a means to expand market share while reducing the administrative requirements of traditional layaway. Merchants are now turning to payment alternatives such as eLayaway(R) in order to take advantage of opportunities that increase sales and profits. Today, approximately one-half of all consumers do not qualify for credit. eLayaway(R) provides an alternative payment method that allows these consumers to make the purchases they desire while enabling merchants to sell additional products on an immediate basis.
In addition to eLayaway.com, the Company also owns and operates eLayawaySPORTS.com, eLayawayTRAVEL.com and eLayawayHEALTH.com. eLayaway, Inc. was founded in 2005.
Press summary, logos and screenshots available for download at: eLayaway.com/press.
Safe Harbor Statement
This report includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for the current fiscal year and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events. Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, the frequency, magnitude and timing of any or all raw-material-price changes, general business and economic conditions beyond the Company's control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace, cost-containment strategies, and the Company's success in attracting and retaining key personnel. Additional information concerning factors that could cause actual results to differ materially from those projected is contained in the Company's filing with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update forward-looking statements that may no longer be accurate or timely as a result of new information.
For more information, please visit www.eLayaway.com.
Contact:
Emerging Growth Research, LLPCarrie Snyder(917) 862-0705
Visit the ELAY showcase profile at Investorideas.com Request News and Info on ELAY Disclosure, Disclaimer/ ELAY is a paid advertising client on Investorideas.com and our tech portals (fiftreen hundred plus five thousand in one fourty four shares).
More Info:
Published at www.Investorideas.com - Global research by sectors
Visit this company: www.eLayaway.com
TALLAHASSEE, Fla. - September 21, 2010 (Investorideas.com newswire) – eLayaway, Inc. (OTCBB:ELAY), the Internet's first and only patent pending layaway payment processor, today announced that merchant retailer Venue(R) has renewed its contract with the Company to continue use of the highly effective eLayaway(R) payment processing system. Venue is a privately-held online merchant and direct retailer of brand-name consumer products that conducts business and sells its products to the public via its popular Venue.com website. For over the past year, Venue has partnered with eLayaway, Inc. to establish Venue.com's user-friendly online payment option called Venue Layaway, a privately-labeled layaway alternative powered by eLayaway(R).
Since implementing the eLayaway(R) payment system under its Venue Layaway private label in June 2009, Venue.com has become a highly satisfied user and advocate of the eLayaway(R) payment system. According to Robert Malina, President of Venue.com, "There was no question we were going to renew our highly successful partnership with eLayaway, Inc. in 2010. Since offering our customers the Venue Layaway payment option, powered by eLayaway(R), our company has benefited by capturing sales that otherwise may not have been possible due to consumer credit challenges." He continued, "Working with eLayaway(R) has been great as they understand our business model, our customers and how we can work together to drive sales while providing customers with access to the items they want from our product line. It's a win-win situation and we see no end in sight for our relationship with eLayaway(R)."
For many online merchants, eLayaway(R) offers an opportunity to affordably provide a layaway payment option to their customers as a means to expand market share while reducing the administrative requirements of traditional layaway, goals that are particularly important in this economic environment in which most merchants are seeking ways to increase sales while consumers are cutting back on their spending habits.
Sergio Pinon, Founder and Chief Marketing Officer of eLayaway, Inc., advised, "The reason we created eLayaway(R) was to assist merchants in successfully reaching their financial objectives while providing their customers with much appreciated, effective payment options that enable them to buy the goods and services they desire. We are very excited to be part of Venue's success, and to be featured prominently on the Venue.com home page under the Shopping section with its private label name, Venue Layaway. We look forward to continuing our relationship with this important client in 2011 and going forward."
How eLayaway Works for Consumers
eLayaway(R) is an online payment system that allows consumers to pay for the products and services they desire using manageable periodic payments, thereby making purchases affordable and easy to budget. Payments are automatically drafted from the consumer's designated bank account via Automated Clearing House ("ACH") on the modifiable schedule set by the consumer at the time of purchase. A flat 1.9% transaction fee is charged to the consumer and all payments are held in an account in trust at HSBC Bank and transferred to the merchant once full payment has been made. Like traditional layaway programs of the past, delivery of the product or service occurs once payment is complete. Payment processing and supporting services are handled by eLayaway(R) while merchants provide order fulfillment.
How eLayaway Works for Merchants
For many online merchants, eLayaway(R) offers an opportunity to provide layaway to their customers as a means to expand market share while reducing the administrative requirements of traditional layaway. Merchants are now turning to payment alternatives such as eLayaway(R) in order to take advantage of opportunities that increase sales and profits. Today, approximately one-half of all consumers do not qualify for credit. eLayaway(R) provides an alternative payment method that allows these consumers to make the purchases they desire while enabling merchants to sell additional products on an immediate basis.
In addition to eLayaway.com, the Company also owns and operates eLayawaySPORTS.com, eLayawayTRAVEL.com and eLayawayHEALTH.com. eLayaway, Inc. was founded in 2005.
Press summary, logos and screenshots available for download at: eLayaway.com/press.
Safe Harbor Statement
This report includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for the current fiscal year and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events. Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, the frequency, magnitude and timing of any or all raw-material-price changes, general business and economic conditions beyond the Company's control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace, cost-containment strategies, and the Company's success in attracting and retaining key personnel. Additional information concerning factors that could cause actual results to differ materially from those projected is contained in the Company's filing with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update forward-looking statements that may no longer be accurate or timely as a result of new information.
For more information, please visit www.eLayaway.com.
Contact:
Emerging Growth Research, LLPCarrie Snyder(917) 862-0705
Visit the ELAY showcase profile at Investorideas.com Request News and Info on ELAY Disclosure, Disclaimer/ ELAY is a paid advertising client on Investorideas.com and our tech portals (fiftreen hundred plus five thousand in one fourty four shares).
More Info:
Published at www.Investorideas.com - Global research by sectors
Today's Biotech/Life Sciences stock news from http://www.investorideas.com/
Investorideas.com updates its Biotech/Life Sciences investors for September 21st.
Q&A Interview with BioSante Pharmaceuticals (NASDAQ: BPAX), A Company Focused on Female Sexual Health and Oncology
Stephen M. Simes, President and Chief Executive Officer, Discusses Potential of Leading Product, LibiGel
September 21, 2010 –(Investorideas.com newswire) www.InvestorIdeas.com, an investor research portal covering leading sectors including biotech stocks and pharma stocks, presents a Q&A interview with BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for investors following the sector.
Read today's news on biotech/life sciences stocks: http://www.investorideas.com/CO/BPAX/news/9211.asp
Want to research Biotech/Life Sciences stocks? Visit our biotech/life sciences stocks portal
http://www.biotechindustrystocks.com/
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get free stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Investorideas.com updates its Biotech/Life Sciences investors for September 21st.
Q&A Interview with BioSante Pharmaceuticals (NASDAQ: BPAX), A Company Focused on Female Sexual Health and Oncology
Stephen M. Simes, President and Chief Executive Officer, Discusses Potential of Leading Product, LibiGel
September 21, 2010 –(Investorideas.com newswire) www.InvestorIdeas.com, an investor research portal covering leading sectors including biotech stocks and pharma stocks, presents a Q&A interview with BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for investors following the sector.
Read today's news on biotech/life sciences stocks: http://www.investorideas.com/CO/BPAX/news/9211.asp
Want to research Biotech/Life Sciences stocks? Visit our biotech/life sciences stocks portal
http://www.biotechindustrystocks.com/
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get free stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Monday, September 20, 2010
Investorideas.com - Mining and Resource Stocks Trading Alert; Actively Trading OTC Stocks ($1.00-$2.00): (MNEAF, SRCH, ROHI, CDXC)
Investorideas.com - Mining and Resource Stocks Trading Alert; Actively Trading OTC Stocks ($1.00-$2.00): (MNEAF, SRCH, ROHI, CDXC)
Point Roberts, WA (Investorideas.com Newswire) September 20, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($1.00-$2.00) include Minera Andes Inc. (OTCBB: MNEAF), Searchlight Minerals Corp. (OTCBB: SRCH), Rotech Healthcare Inc. (OTCBB: ROHI), and ChromaDex Corp. (OTCBB: CDXC).
OTC/Market Commentary:
Trading Alert: (at time of release)Searchlight Minerals Corp. (OTCBB: SRCH); trading at $ 1.34 USD, up 0.32 (31.37%)
One of the OTCBB volume leaders; Searchlight Minerals Corp. (OTCBB: SRCH): "Searchlight Minerals Corp. is an exploration stage company engaged in the acquisition and exploration of mineral properties and slag reprocessing projects. The Company holds interests in two mineral projects: (i) the Clarkdale Slag Project, located in Clarkdale, Arizona, which is a reclamation project to recover precious and base metals from the reprocessing of slag produced from the smelting of copper ore mined at the United Verde Copper Mine in Jerome, Arizona; and (ii) the Searchlight Gold Project, which involves exploration for precious metals on mining claims near Searchlight, Nevada. The Clarkdale Slag Project is the more advanced of two ongoing projects that the Company is pursuing. The Searchlight Gold Project is an early-stage gold exploration endeavor on 3,200 acres located approximately 50 miles south of Las Vegas, Nevada."
Market Snapshot: (at time of release)
Dow 10,707.72 +99.87 +0.94%
Nasdaq 2,338.53 +22.92 +0.99%
S&P 500 1,136.56 +10.97 +0.97%
10 Yr Bond(%) 2.7230% -0.2300
Oil 75.13 +1.47 +2.00%
Gold 1,282.00 +6.40 +0.50%
OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today! Sign up for Tomorrows Hot OTC Market Leaders Today!http://bit.ly/otcvolumeleaders
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
* Attention Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC Securities
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Point Roberts, WA (Investorideas.com Newswire) September 20, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($1.00-$2.00) include Minera Andes Inc. (OTCBB: MNEAF), Searchlight Minerals Corp. (OTCBB: SRCH), Rotech Healthcare Inc. (OTCBB: ROHI), and ChromaDex Corp. (OTCBB: CDXC).
OTC/Market Commentary:
Trading Alert: (at time of release)Searchlight Minerals Corp. (OTCBB: SRCH); trading at $ 1.34 USD, up 0.32 (31.37%)
One of the OTCBB volume leaders; Searchlight Minerals Corp. (OTCBB: SRCH): "Searchlight Minerals Corp. is an exploration stage company engaged in the acquisition and exploration of mineral properties and slag reprocessing projects. The Company holds interests in two mineral projects: (i) the Clarkdale Slag Project, located in Clarkdale, Arizona, which is a reclamation project to recover precious and base metals from the reprocessing of slag produced from the smelting of copper ore mined at the United Verde Copper Mine in Jerome, Arizona; and (ii) the Searchlight Gold Project, which involves exploration for precious metals on mining claims near Searchlight, Nevada. The Clarkdale Slag Project is the more advanced of two ongoing projects that the Company is pursuing. The Searchlight Gold Project is an early-stage gold exploration endeavor on 3,200 acres located approximately 50 miles south of Las Vegas, Nevada."
Market Snapshot: (at time of release)
Dow 10,707.72 +99.87 +0.94%
Nasdaq 2,338.53 +22.92 +0.99%
S&P 500 1,136.56 +10.97 +0.97%
10 Yr Bond(%) 2.7230% -0.2300
Oil 75.13 +1.47 +2.00%
Gold 1,282.00 +6.40 +0.50%
OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today! Sign up for Tomorrows Hot OTC Market Leaders Today!http://bit.ly/otcvolumeleaders
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
* Attention Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC Securities
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Today's Agriculture stock news from http://www.investorideas.com/
Investorideas.com updates its Agriculture stocks investors for September 20th.
Ag Stocks Trading in the Green; (OTCBB: AQUM), (NYSE: MOS), (NasdaqCM: COIN), (NYSE: POT)
Potash (NYSE: POT) trading at $148.49, up $1.21
Sept 20, 2010 - www.InvestorIdeas.com, a leader in sector research for independent investor’s reports on Agriculture stocks trading for Sept 20, 2010. As the Dow and NASDAQ see gains on the day, the agriculture stock sector sees green.
Read today's news on Agriculture stocks: http://www.investorideas.com/CO/AQUM/news/9201.asp
Want to research Agriculture stocks? Visit our Agriculture stocks directory
http://www.investorideas.com/MSS/Arg_Stock_List.asp
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Investorideas.com updates its Agriculture stocks investors for September 20th.
Ag Stocks Trading in the Green; (OTCBB: AQUM), (NYSE: MOS), (NasdaqCM: COIN), (NYSE: POT)
Potash (NYSE: POT) trading at $148.49, up $1.21
Sept 20, 2010 - www.InvestorIdeas.com, a leader in sector research for independent investor’s reports on Agriculture stocks trading for Sept 20, 2010. As the Dow and NASDAQ see gains on the day, the agriculture stock sector sees green.
Read today's news on Agriculture stocks: http://www.investorideas.com/CO/AQUM/news/9201.asp
Want to research Agriculture stocks? Visit our Agriculture stocks directory
http://www.investorideas.com/MSS/Arg_Stock_List.asp
We have some of the most comprehensive stock directories online. Also subscribe to our free news feeds.
Get stock alerts on our showcase stocks - see our latest companies
http://www.investorideas.com/Resources/Newsletter.asp
The team at Investorideas.com - - Investor Ideas that can Change the World
Investorideas.com - Water Stocks News; Wescorp (OTCBB:WSCE) Updates 30-Day Operation of H2Omaxx Oil-Water Separation Technology at Cancen Oil
Investorideas.com - Water Stocks News; Wescorp (OTCBB:WSCE) Updates 30-Day Operation of H2Omaxx Oil-Water Separation Technology at Cancen Oil
New Data Expands H2Omaxx Performance Range - Effectively Reducing 40+% Contaminated Hydrocarbon Waste Water to Less than 12 Parts Per Million
CALGARY, ALBERTA - September 20, 2010 (Investorideas.com Water Stocks Newswire) - Wescorp Energy Inc. (OTC.BB:WSCE), a clean water technology company focused on implementing its low-cost solutions into several markets including the oil & gas and marine industries, provided an update today that the Company's H2Omaxx oil-water separation unit has completed its initial 30-day commercial operations at Cancen Oil Canada Corporation's New Sarepta facility. The Company has confirmed new operating capabilities for the H2Omaxx clean water technology; cleaning 40+% contaminated hydrocarbon waste water to less than 12 ppm oil.
Overview of 30 day operation – summary:
In July, Wescorp commenced a 30-day continuous commercial test of H2Omaxx to define a number of operating parameters, including heat requirements and treatment time.
The unit ran successfully and reliably, meeting Cancen's operational needs by treating approximately 3,500 barrels of contaminated fluid.
Unexpectedly, the fluid received was from oil sands operations, and was heavily contaminated with hydrocarbons. The oil/water mixture was in the range of 10-40% plus oil - contaminated. The H2Omaxx has historically treated oil/water mixture in the 3-5% range.
The H2Omaxx successfully treated the 40/60 mixture by cycling the fluid through the treatment process a number of times, rather than a single pass through which is normal for less contaminated fluid.
The batch treatment of the mixture achieved Cancen's standards for fluid disposal in its disposal well. While Wescorp was subject to the operational pressures of Cancen's site, Wescorp was permitted to undertake a multi-cycle treatment process of one tank of heavily contaminated fluid, under conditions which permit replication, in order to verify the operating range of the H2Omaxx.
Inlet and post-treatment outlet samples were taken. Lab results from ALS Laboratory Group establish that the H2Omaxx successfully received fluids contaminated at 40%+ (by volume) level, and discharged a cleaned fluid at less than 12 ppm hydrocarbons.
Treatment of this level of hydrocarbon contamination without extensive heat, chemicals or filters is, in Management's judgment, exceptional.
Wescorp believes that the next stage of testing should focus on defining what level of contamination requires only one treatment cycle, and what level of contamination requires repeated treatment cycles, also known as batch treatment.
"This 30-day operating period is important for several reasons," states Robert G. Power, Executive Chairman of Wescorp. "First, Wescorp's H2Omaxx technology has passed the research stage and we are now focusing on scalability and the range of hydrocarbon contamination to treat. Second, we have again proved the technology's operational reliability – a critical issue with many competing technologies.
"Third, we learned that the H2Omaxx can successfully treat fluids with a dramatically higher percentage of contaminates than historically treated. We believe that this expanded upper treatment range opens up significant new market potential.
"We caution readers that these results now need to be replicated in additional operating scenarios. The reality of oil field waste fluid treatments is that there is a wide range of hydrocarbon contamination and related chemical contamination. Further testing is required. However, these results demonstrate H2Omaxx's highly effective ability to clean some of the most contaminated waste in the oil industry without the use of filters, chemicals or heat."
H2Omaxx Technology
H2Omaxx has been proven to be a safe, effective, economical and environmentally friendly process for cleaning and separating oil and solids from water.
Using Wescorp's nano-aeration technology, previous independent test results have shown the H2Omaxx technology to reduce the oil content in produced water to less than 10 parts per million without the use of chemicals, filters or heat.
Use of H2Omaxx provides important cost benefits to the operator when compared with the traditional multi-technology approach to remediate water.
H2Omaxx can lower both the operator's capital costs and operating costs significantly. In addition, new revenues are created by the capture of barrels of oil that would otherwise be disposed.
The H2Omaxx technology has been designed to produce the H2Omaxx unit in a variety of sizes, including a mobile unit and commercial units (2,500, 10,000 and 65,000 barrels-per-day).
10,000 BPD Mobile Unit
Wescorp previously announced that it will be taking delivery of a new 10,000 barrel-per-day H2Omaxx unit, designed and built by K-Line Trailers Ltd. (www.klinetrailers.com). Because delivery of a component is not expected to be received by K-Line until mid October, Wescorp presently expects to receive the completed unit by early November. After completion of the commissioning phase, the mobile unit, which is designed to be rapidly transported to remote locations, will be available to be marketed for potential customer sites, initially in Western Canada. Wescorp also intends to market the unit's services in the Gulf of Mexico area.
The mobile, 10,000 barrel-per-day unit is designed to be placed swiftly on sites for the purposes of demonstrating the technology and for use for short-term commercial operations. The unit will have its own storage, separation and containment tanks, micro-aeration generators, and firmware and computer automation technology to allow water remediation with minimal human supervision.
About Wescorp
Wescorp Energy Inc. (www.wescorpenergy.com) is a clean water solutions company focused on implementing its superior yet low cost solutions into the oil and gas production industry.
Safe Harbor Statement
Any statements contained herein that are not historical facts may be forward-looking statements, and involve risks and uncertainties. Potential factors could cause actual results to differ materially from those expressed or implied by such statements. Information on the potential factors that could affect the Company's actual results of operations is included in its filings with the Securities and Exchange Commission. These risks may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the Securities and Exchange Commission in the future.
Investor Relations Contact:
Bibicoff + MacInnis, Inc.Terri MacInnis, Dir. of Investor Relations818-379-8500terri@bibimac.com
Visit the WSCE showcase profile at Investorideas.com Request News and Info on WSCE Disclosure, Disclaimer/ WSCE is a paid advertising client on Investorideas.com and our water and renewable-energy portals (twenty five hundred from 3rd party plus stock options at .25)
Turn to a leader for investing in waterInvestorideas.com and www.water-stocks.com
Research Global Water StocksVisit our Water Stocks Directory
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
New Data Expands H2Omaxx Performance Range - Effectively Reducing 40+% Contaminated Hydrocarbon Waste Water to Less than 12 Parts Per Million
CALGARY, ALBERTA - September 20, 2010 (Investorideas.com Water Stocks Newswire) - Wescorp Energy Inc. (OTC.BB:WSCE), a clean water technology company focused on implementing its low-cost solutions into several markets including the oil & gas and marine industries, provided an update today that the Company's H2Omaxx oil-water separation unit has completed its initial 30-day commercial operations at Cancen Oil Canada Corporation's New Sarepta facility. The Company has confirmed new operating capabilities for the H2Omaxx clean water technology; cleaning 40+% contaminated hydrocarbon waste water to less than 12 ppm oil.
Overview of 30 day operation – summary:
In July, Wescorp commenced a 30-day continuous commercial test of H2Omaxx to define a number of operating parameters, including heat requirements and treatment time.
The unit ran successfully and reliably, meeting Cancen's operational needs by treating approximately 3,500 barrels of contaminated fluid.
Unexpectedly, the fluid received was from oil sands operations, and was heavily contaminated with hydrocarbons. The oil/water mixture was in the range of 10-40% plus oil - contaminated. The H2Omaxx has historically treated oil/water mixture in the 3-5% range.
The H2Omaxx successfully treated the 40/60 mixture by cycling the fluid through the treatment process a number of times, rather than a single pass through which is normal for less contaminated fluid.
The batch treatment of the mixture achieved Cancen's standards for fluid disposal in its disposal well. While Wescorp was subject to the operational pressures of Cancen's site, Wescorp was permitted to undertake a multi-cycle treatment process of one tank of heavily contaminated fluid, under conditions which permit replication, in order to verify the operating range of the H2Omaxx.
Inlet and post-treatment outlet samples were taken. Lab results from ALS Laboratory Group establish that the H2Omaxx successfully received fluids contaminated at 40%+ (by volume) level, and discharged a cleaned fluid at less than 12 ppm hydrocarbons.
Treatment of this level of hydrocarbon contamination without extensive heat, chemicals or filters is, in Management's judgment, exceptional.
Wescorp believes that the next stage of testing should focus on defining what level of contamination requires only one treatment cycle, and what level of contamination requires repeated treatment cycles, also known as batch treatment.
"This 30-day operating period is important for several reasons," states Robert G. Power, Executive Chairman of Wescorp. "First, Wescorp's H2Omaxx technology has passed the research stage and we are now focusing on scalability and the range of hydrocarbon contamination to treat. Second, we have again proved the technology's operational reliability – a critical issue with many competing technologies.
"Third, we learned that the H2Omaxx can successfully treat fluids with a dramatically higher percentage of contaminates than historically treated. We believe that this expanded upper treatment range opens up significant new market potential.
"We caution readers that these results now need to be replicated in additional operating scenarios. The reality of oil field waste fluid treatments is that there is a wide range of hydrocarbon contamination and related chemical contamination. Further testing is required. However, these results demonstrate H2Omaxx's highly effective ability to clean some of the most contaminated waste in the oil industry without the use of filters, chemicals or heat."
H2Omaxx Technology
H2Omaxx has been proven to be a safe, effective, economical and environmentally friendly process for cleaning and separating oil and solids from water.
Using Wescorp's nano-aeration technology, previous independent test results have shown the H2Omaxx technology to reduce the oil content in produced water to less than 10 parts per million without the use of chemicals, filters or heat.
Use of H2Omaxx provides important cost benefits to the operator when compared with the traditional multi-technology approach to remediate water.
H2Omaxx can lower both the operator's capital costs and operating costs significantly. In addition, new revenues are created by the capture of barrels of oil that would otherwise be disposed.
The H2Omaxx technology has been designed to produce the H2Omaxx unit in a variety of sizes, including a mobile unit and commercial units (2,500, 10,000 and 65,000 barrels-per-day).
10,000 BPD Mobile Unit
Wescorp previously announced that it will be taking delivery of a new 10,000 barrel-per-day H2Omaxx unit, designed and built by K-Line Trailers Ltd. (www.klinetrailers.com). Because delivery of a component is not expected to be received by K-Line until mid October, Wescorp presently expects to receive the completed unit by early November. After completion of the commissioning phase, the mobile unit, which is designed to be rapidly transported to remote locations, will be available to be marketed for potential customer sites, initially in Western Canada. Wescorp also intends to market the unit's services in the Gulf of Mexico area.
The mobile, 10,000 barrel-per-day unit is designed to be placed swiftly on sites for the purposes of demonstrating the technology and for use for short-term commercial operations. The unit will have its own storage, separation and containment tanks, micro-aeration generators, and firmware and computer automation technology to allow water remediation with minimal human supervision.
About Wescorp
Wescorp Energy Inc. (www.wescorpenergy.com) is a clean water solutions company focused on implementing its superior yet low cost solutions into the oil and gas production industry.
Safe Harbor Statement
Any statements contained herein that are not historical facts may be forward-looking statements, and involve risks and uncertainties. Potential factors could cause actual results to differ materially from those expressed or implied by such statements. Information on the potential factors that could affect the Company's actual results of operations is included in its filings with the Securities and Exchange Commission. These risks may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the Securities and Exchange Commission in the future.
Investor Relations Contact:
Bibicoff + MacInnis, Inc.Terri MacInnis, Dir. of Investor Relations818-379-8500terri@bibimac.com
Visit the WSCE showcase profile at Investorideas.com Request News and Info on WSCE Disclosure, Disclaimer/ WSCE is a paid advertising client on Investorideas.com and our water and renewable-energy portals (twenty five hundred from 3rd party plus stock options at .25)
Turn to a leader for investing in waterInvestorideas.com and www.water-stocks.com
Research Global Water StocksVisit our Water Stocks Directory
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Subscribe to:
Posts (Atom)